Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sarepta Therapeutics (NQ: SRPT )

83.21 USD -1.58 (-1.86%)
Official Closing Price Updated: 7:59 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Sarepta Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
65 66 Next >
RSI Alert: Sarepta Therapeutics (SRPT) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Sarepta Therapeutics (SRPT) Q4 2020 Earnings Call Transcript
SRPT earnings call for the period ending December 31, 2020. 
Tags Market News SRPT
From Motley Fool
10 Stocks Moving In Monday's After-Hours Session
Gainers Zoom Video Communications (NASDAQ: ZM) shares are trading higher after the company reported better-than-expected Q4 EPS ... 
Tags Movers SWCH TVTX
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 31.41% to $6.61 during Monday's after-market session. Trading volume for ... 
Tags ARAY General ASRT
From Benzinga
Recap: Sarepta Therapeutics Q4 Earnings
Shares of Sarepta Therapeutics (NASDAQ:SRPT) decreased in after-market trading after the company reported Q4 results. Quarterly ... 
Tags Market News SRPT Benzinga
From Benzinga
Earnings Scheduled For March 1, 2021
Companies Reporting Before The Bell • Athenex (NASDAQ:ATNX) is likely to report quarterly loss at $0.44 per share on ... 
Tags CCXI OMER Market News
From Benzinga
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Most Food and Drug Administration decisions scheduled for February were positive, and more importantly five new molecular entities ... 
Tags BMY News Penny Stocks
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags FBIO RGNX EVAX
From Benzinga
Earnings Preview: Sarepta Therapeutics
Sarepta Therapeutics (NASDAQ:SRPT) announces its next round of earnings this Monday, March 01. Here is Benzinga's ... 
Tags Market News SRPT Earnings
From Benzinga
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FDA CYTK DRNA
From Benzinga
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags INSP FDA SGMO
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning trading, 22 companies set new 52-week lows. Points of Interest: Viatris ... 
Tags Intraday Update AFIB DGNR
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags NTLA PRVB CLNN
From Benzinga
How Will Biden's Executive Orders Affect Your Healthcare Stocks?
The decisions could have both short- and long-term implications. 
Tags FLGT Market News LH
From Motley Fool
FBT's Underlying Holdings Could Mean 16% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Repligen Stock Doubled In 2020 — Why Covid Demand Is Fueling It
When it comes to coronavirus vaccines, think of Repligen as the man behind the curtain and RGEN stock as a tools powerhouse. Shares broke out of a cup base in January and hover in a buy zone. 
From Investor's Business Daily
Sarepta Therapeutics Larger Than S&P 500 Component Kimco Realty
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Sarepta Therapeutics Inc (SRPT) was identified as having a larger market cap than the smaller end of the... 
Tags Stocks
From Market News Video
Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates
Coming off a stellar year, when a record 53 new molecular entities were approved, 2021 has a lot to live up to. NMEs are a measure of ... 
Tags MRK Biotech CRMD
From Benzinga
Pfizer Stock 2021: A Lean, Mean, Covid-Fighting Machine?
Pfizer sees coronavirus vaccines as a "durable" business, one executive said recently. But don't expect Pfizer stock to be hung up on Covid-19 in 2021. The company sees plenty of catalysts. 
From Investor's Business Daily
Noteworthy Wednesday Option Activity: CALX, CCS, SRPT
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Calix Inc (CALX), where a total volume of 4,022 contracts has been traded thus far... 
Tags Stocks
From Market News Video
Benzinga's Top Upgrades, Downgrades For January 12, 2021
Upgrades According to B of A Securities, the prior rating for Charles Schwab Corp (NYSE:SCHW) was changed from Neutral ... 
Tags AEP NOV POR
From Benzinga
84 Biggest Movers From Yesterday
Gainers Zomedica Corp. (NYSE: ZOM) shares surged 92.2% to close at $0.93 on Monday after surging 21% on Friday. The company, last ... 
Tags IPDN RIOT Market News
From Benzinga
63 Stocks Moving In Monday's Mid-Day Session
Gainers Zomedica Corp. (NYSE: ZOM) shares jumped 77.5% to $0.8591 after surging 21% on Friday. The company, last week, appointed ... 
Tags GTE AVGR NVIV
From Benzinga
50 Stocks Moving in Monday's Pre-Market Session
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares rose 101% to $4.28 in pre-market trading. LM Funding shares jumped 177% on ... 
Tags MESO TWTR CAN
From Benzinga
82 Biggest Movers From Friday
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 177% to close at $2.13on Friday after the company announced ... 
Tags Movers From Friday Small Cap Electronic Equipment Manufacturers
From Benzinga
Here's Why Sarepta Therapeutics Lost Support on Wall Street
Disappointing trial results caused a flock of analysts to drop their ratings on this biotech stock. 
Tags RHHBY JPM SRPT
From Motley Fool
The Week Ahead In Biotech (Jan. 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
After ending 2020 in the green, biotech stocks had a strong start to 2021, partly capitalizing on the broader strength markets saw this past week despite political turmoil at Capitol Hill. The week... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
JPMorgan Chase & Co. CEO Jamie Dimon is to be among the keynote speakers at next week'sJ.P. Morgan Healthcare ... 
Tags ZLAB Top Stories AZN
From Benzinga
Noteworthy Friday Option Activity: SRPT, TTD, ROKU
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sarepta Therapeutics Inc (SRPT), where a total of 78,297 contracts have traded so far,... 
Tags Stocks
From Market News Video
Mid-Afternoon Market Update: Gold Dips 3.5%; Merus Shares Surge
Toward the end of trading Friday, the Dow traded down 0.27% to 30,956.01 while the NASDAQ rose 0.36% to 13,114.70. The S&P also ... 
Tags Small Cap Markets CMRX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
65 66 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.